fda warning letters compounding semaglutide september 2025 issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA warns telehealth companies over

Engagement rate for 4 or more weeks based on Noom app engagement data for November 2025 Noom Microdose GLP-1 Rx Program users, based on their first-ever log-in date

[PMID: 16534956] PubMed record related to this compound for laboratory literature review

This is a familiarization period, not a treatment dose

Weighing the pros and cons of switching medications should be done in consultation with a healthcare provider to ensure continued effective management of diabetes or weight loss

While these trials used different populations and durations, the magnitude difference has driven clinicians to consider tirzepatide when patients plateau on semaglutide

Can You Come Off GLP-1